← Open Payments lookup

ADRIANNE ECHELBARGER: Open Payments

NPI 1588058614 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,148 in 49 payments from 15 companies in 2025. Trend: 2023 $774 · 2024 $834 · 2025 $1,148

Food & beverage: $1,148
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$178
Takeda Pharmaceuticals U.S.A., Inc.7$156
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$124
Regeneron Healthcare Solutions, Inc.5$115
GENZYME CORPORATION4$114
GlaxoSmithKline, LLC.6$114
Viatris Specialty LLC4$66
ABBVIE INC.2$51
Merck Sharp & Dohme LLC3$45
Amgen Inc.2$40

Products named: DUPIXENT, GLASSIA, XIFAXAN, TEZSPIRE, NUCALA, FASENRA, YUPELRI, Prolastin-C Liquid.

Industry payments across IN — which companies pay providers there.